Clinical Trial Update: Voriconazole for IPA in Chinese Patients With COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating voriconazole for invasive pulmonary aspergillosis in Chinese patients with COPD; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Invasive Pulmonary Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Red Cross Hospital, Hangzhou, China | Conditions: Invasive Pulmonary Aspergillosis, COPD | Phase 4 | Status: UNKNOWN